Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective

Anastasia Glazyrina1, Elena Zholobova2, Ekaterina Iakovleva3

  • 1Morozovskaya Children's Municipal Clinical Hospital of the Moscow City Health Department, Moscow, Russia.

PubMed
Abstract

Insights

Most children with Multisystem Inflammatory Syndrome in children (MIS-C) recover well, with few experiencing lasting symptoms or inflammation markers six weeks after discharge. This study tracked MIS-C outcomes in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Cardiology

Background:

  • Multisystem Inflammatory Syndrome in children (MIS-C) incidence is decreasing but remains a global concern.
  • Understanding MIS-C consequences is crucial for disease prognosis.
  • This study assesses short- and medium-term clinical outcomes of MIS-C.

Purpose of the Study:

  • To evaluate the clinical outcomes of children diagnosed with MIS-C.
  • To assess the resolution of inflammatory markers and symptoms post-discharge.
  • To identify any persistent echocardiographic abnormalities.

Main Methods:

  • Prospective observational cohort study conducted in Moscow, Russia.
  • Included 37 children meeting established MIS-C case definitions (RCPCH, CDC, WHO).
  • Follow-up assessments at 2 and 6 weeks post-discharge included clinical evaluation and laboratory tests.

Main Results:

  • 37 children (median age 6 years, 59.5% boys) were studied; 48.6% required ICU care.
  • 35.1% had abnormal echocardiographic findings during the acute phase.
  • By 6 weeks, only 5.6% reported symptoms, inflammatory markers normalized in all, and one child had persistent coronary dilatation.

Conclusions:

  • The majority of children with MIS-C experienced full recovery.
  • Few children had persistent symptoms or elevated inflammatory markers at 6 weeks.
  • Persistent echocardiographic abnormalities were rare, observed in only one case.

Related Concept Videos